Connor Clark & Lunn Investment Management Ltd. Invests $5.67 Million in Oscar Health, Inc. (NYSE:OSCR)

Connor Clark & Lunn Investment Management Ltd. bought a new stake in Oscar Health, Inc. (NYSE:OSCR) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 421,993 shares of the company’s stock, valued at approximately $5,672,000.

Other hedge funds have also bought and sold shares of the company. State Street Corp increased its position in shares of Oscar Health by 6.0% during the 3rd quarter. State Street Corp now owns 5,132,802 shares of the company’s stock valued at $108,867,000 after purchasing an additional 291,335 shares during the last quarter. Lingotto Investment Management LLP bought a new position in Oscar Health during the fourth quarter valued at about $2,543,000. GDS Wealth Management increased its holdings in Oscar Health by 1,545.3% during the fourth quarter. GDS Wealth Management now owns 345,817 shares of the company’s stock worth $4,648,000 after buying an additional 324,798 shares during the last quarter. Nordea Investment Management AB bought a new stake in Oscar Health in the fourth quarter worth about $1,056,000. Finally, Janney Montgomery Scott LLC purchased a new position in Oscar Health in the third quarter valued at about $988,000. 75.70% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages have recently issued reports on OSCR. Wells Fargo & Company lowered shares of Oscar Health from an “overweight” rating to an “equal weight” rating and decreased their price target for the stock from $20.00 to $16.00 in a research note on Thursday. Jefferies Financial Group started coverage on Oscar Health in a research report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 target price for the company. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $20.19.

Oscar Health Stock Performance

NYSE:OSCR opened at $13.23 on Friday. Oscar Health, Inc. has a 52-week low of $12.43 and a 52-week high of $23.79. The business’s fifty day moving average is $15.21 and its 200 day moving average is $16.38. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The firm has a market cap of $3.31 billion, a price-to-earnings ratio of -660.92 and a beta of 1.75.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Research analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.